Israel’s Renewal Bio, a startup spun out of Israel’s Weizmann Institute, is turning skin cells into stem cells that can be grown into replacement organs for cancer patients or to cure rare orphan diseases. They simulate embryonic development – and … Continue reading →

Jan 2026, saw the highest number of organ transplants ever recorded in Israel in a single month – 54 on 47 patients. 7 hearts, 9 lungs (including 7 doubles), 9 livers, and 21 kidneys. The previous record was 36 transplants … Continue reading →

A delegation of ten top Israeli genomics and biodata experts visited the UK to explore new channels for joint innovation in the life sciences. Meetings took place in London’s Knowledge Quarter research cluster included at University College London and the … Continue reading →

Tel Aviv University researchers have discovered that facial mimicry (copying a speaker’s facial movements) can reveal preferences better than interpreting smiles, frowns etc. The team used unique technology to track micro-movements of the face that are invisible to the naked … Continue reading →

Surgeons at Rambam Medical Center used deep brain stimulation on a patient with severe Obsessive–Compulsive Disorder that failed to respond to medication or psychotherapy. Four electrodes were implanted in two separate regions of the brain, handling anxiety, emotional regulation, & … Continue reading →

Weizmann scientists are now developing Israeli-invented CAR-T cancer therapy (see here previously) to cure brain diseases such as Alzheimer’s. The team of Israeli and American scientists have modified T cells to recognize and respond to amyloid proteins in the brain. … Continue reading →

A Tel Aviv University-led international team, has deciphered a mechanism that enables breast cancer to metastasize to the brain. They found an anomaly in chromosome 17 and faulty p53 (“genome guardian”) genes increased the risk of cancer spread. Inhibiting the … Continue reading →

Technion and top US university researchers have conducted lab trials of an implantable ‘living pancreas’. It senses glucose, produces insulin, while its crystalline shield prevents immune system rejection. It paves the way for self-regulating, long-term diabetes treatment without daily injections. … Continue reading →

Israel’s AccuLine (see here previously) conducted a trial of its CORA non-invasive coronary artery test on 305 heart patients. It was 94% correct in predicting blockages and 99% correct in giving the all-clear. Easier, faster, cheaper or more accurate than … Continue reading →